Shire extends tender offer for ViroPharma buyout
MLex Summary: Nasdaq-listed Irish pharmaceutical company Shire Pharmaceutical has extended to midnight on Jan. 23 the deadline for its $4.2 billion tender offer for Nasdaq-listed international biopharmaceutical company ViroPharma, according to a US Securities and Exchange Commission...To view the full article, register now.
Already a subscriber? Click here to view full article